Canlyniadau Chwilio - Liu, Feiyang

The Influence of Chinese College Students’ Physical Exercise on Life Satisfaction: The Chain Mediation Effect of Core Self-evaluation and Positive Emotion gan Liu, Feiyang, Zhu, Zhengguang, Jiang, Bo

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Intelligently chosen interventions have potential to outperform the diode bridge in power conditioning gan Liu, Feiyang, Zhang, Yulong, Dahlsten, Oscar, Wang, Fei

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficient Organic Light Emitting Diodes Using Solution-Processed Alkali Metal Carbonate Doped ZnO as Electron Injection Layer gan Chen, Guo, Liu, Feiyang, Ling, Zhitian, Zhang, Pengpeng, Wei, Bin, Zhu, Wenqing

Cael y testun llawn Cael y testun llawn Cael y testun llawn

HOCl‐Activated Aggregation of Gold Nanoparticles for Multimodality Therapy of Tumors gan Liu, Dongya, Liu, Lingyan, Liu, Feiyang, Zhang, Mengfan, Wei, Peng, Yi, Tao

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Gemcitabine and Chk1 inhibitor AZD7762 synergistically suppress the growth of Lkb1-deficient lung adenocarcinoma gan Liu, Yan, Li, Yuyang, Wang, Xiaoen, Liu, Feiyang, Gao, Peng, Quinn, Max M., Li, Fei, Merlino, Ashley A, Benes, Cyril, Liu, Qingsong, Gray, Nathanael, Wong, Kwok-kin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Up-regulation of IGF-1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small molecule inhibition of IGF-1R gan Weisberg, Ellen, Nonami, Atsushi, Chen, Zhao, Nelson, Erik, Chen, Yongfei, Liu, Feiyang, Cho, Haeyeon, Zhang, Jianming, Sattler, Martin, Mitsiades, Constantine, Wong, Kwok-Kin, Liu, Qingsong, Gray, Nathanael, Griffin, James D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells gan Weisberg, Ellen, Liu, Qingsong, Zhang, Xin, Nelson, Erik, Sattler, Martin, Liu, Feiyang, Nicolais, Maria, Zhang, Jianming, Mitsiades, Constantine, Smith, Robert W., Stone, Richard, Galinsky, Ilene, Nonami, Atsushi, Griffin, James D., Gray, Nathanael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours gan Liu, Juan, Gao, Jingjing, Wang, Aoli, Jiang, Zongru, Qi, Shuang, Qi, Ziping, Liu, Feiyang, Yu, Kailin, Cao, Jiangyan, Chen, Cheng, Hu, Chen, Wu, Hong, Wang, Li, Wang, Wenchao, Liu, Qingsong, Liu, Jing

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor gan Kim, Hyung-Gu, Tan, Li, Weisberg, Ellen L., Liu, Feiyang, Canning, Peter, Choi, Hwan-Geun, Ezell, Scott, Zhao, Zheng, Wu, Hong, Wang, Jinhua, Mandinova, Anna, Bullock, Alex N., Liu, Qingsong, Lee, Sam W., Gray, Nathanael S.

Cael y testun llawn Cael y testun llawn

Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor gan Kim, Hyung-Gu, Tan, Li, Weisberg, Ellen L., Liu, Feiyang, Canning, Peter, Choi, Hwan Geun, Ezell, Scott A., Wu, Hong, Zhao, Zheng, Wang, Jinhua, Mandinova, Anna, Griffin, James D., Bullock, Alex N., Liu, Qingsong, Lee, Sam W., Gray, Nathanael S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Axitinib overcomes multiple imatinib resistant cKIT mutations including the gatekeeper mutation T670I in gastrointestinal stromal tumors gan Liu, Feiyang, Zou, Fengming, Chen, Cheng, Yu, Kailin, Liu, Xiaochuan, Qi, Shuang, Wu, Jiaxin, Hu, Chen, Hu, Zhenquan, Liu, Juan, Liu, Xuesong, Wang, Li, Ge, Juan, Wang, Wenchao, Ren, Tao, Bai, Mingfeng, Cai, Yujiao, Xiao, Xudong, Qian, Feng, Tang, Jun, Liu, Qingsong, Liu, Jing

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Dual inhibition of AKT/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML gan Wang, Aoli, Wu, Hong, Chen, Cheng, Hu, Chen, Qi, Ziping, Wang, Wenchao, Yu, Kailin, Liu, Xiaochuan, Zou, Fengming, Zhao, Zheng, Wu, Jiaxin, Liu, Juan, Liu, Feiyang, Wang, Li, Stone, Richard M., Galinksy, Ilene A., Griffin, James D., Zhang, Shanchun, Weisberg, Ellen L., Liu, Jing, Liu, Qingsong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML) gan Liu, Feiyang, Wang, Beilei, Wang, Qiang, Qi, Ziping, Chen, Cheng, Kong, Lu-Lu, Chen, Ji-Yun, Liu, Xiaochuan, Wang, Aoli, Hu, Chen, Wang, Wenchao, Wang, Huiping, Wu, Fan, Ruan, Yanjie, Qi, Shuang, Liu, Juan, Zou, Fengming, Hu, Zhenquan, Wang, Wei, Wang, Li, Zhang, Shanchun, Yun, Cai-Hong, Zhai, Zhimin, Liu, Jing, Liu, Qingsong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Discovery of a Potent, Covalent BTK Inhibitor for B-Cell Lymphoma gan Wu, Hong, Wang, Wenchao, Liu, Feiyang, Weisberg, Ellen L., Tian, Bei, Chen, Yongfei, Li, Binhua, Wang, Aoli, Wang, Beilei, Zhao, Zheng, McMillin, Douglas W., Hu, Chen, Li, Hong, Wang, Jinhua, Liang, Yanke, Buhrlage, Sara J., Liang, Junting, Liu, Jing, Yang, Guang, Brown, Jennifer R., Treon, Steven P., Mitsiades, Constantine S., Griffin, James D., Liu, Qingsong, Gray, Nathanael S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Characterization of selective and potent PI3Kδ inhibitor (PI3KD-IN-015) for B-Cell malignances gan Liu, Xiaochuan, Wang, Aoli, Liang, Xiaofei, Chen, Cheng, Liu, Juanjuan, Zhao, Zheng, Wu, Hong, Deng, Yuanxin, Wang, Li, Wang, Beilei, Wu, Jiaxin, Liu, Feiyang, Fernandes, Stacey M., Adamia, Sophia, Stone, Richard M., Galinsky, Ilene A., Brown, Jennifer R., Griffin, James D., Zhang, Shanchun, Loh, Teckpeng, Zhang, Xin, Wang, Wenchao, Weisberg, Ellen L., Liu, Jing, Liu, Qingsong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies gan Liu, Xiaochuan, Wang, Aoli, Liang, Xiaofei, Liu, Juanjuan, Zou, Fengming, Chen, Cheng, Zhao, Zheng, Deng, Yuanxin, Wu, Hong, Qi, Ziping, Wang, Beilei, Wang, Li, Liu, Feiyang, Xu, Yunhe, Wang, Wenchao, Fernandes, Stacey M., Stone, Richard M., Galinsky, Ilene A., Brown, Jennifer R., Loh, Teckpeng, Griffin, James. D., Zhang, Shanchun, Weisberg, Ellen L., Zhang, Xin, Liu, Jing, Liu, Qingsong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences gan Wang, Aoli, Sun, Yong, Liu, Qingwang, Wu, Hong, Liu, Juan, He, Jun, Yu, Junling, Chen, Qing Qing, Ge, Yinglu, Zhang, Zhuhui, Hu, Chen, Chen, Cheng, Qi, Ziping, Zou, Fengming, Liu, Feiyang, Hu, Jie, Zhao, Ming, Huang, Tao, Wang, Beilei, Wang, Li, Wang, Wei, Wang, Wenchao, Ren, Tao, Liu, Jing, Sun, Yehuan, Fan, Song, Wu, Qibing, Liang, Chaozhao, Sun, Liangdan, Su, Bin, Wei, Wei, Liu, Qingsong

Cael y testun llawn Cael y testun llawn Cael y testun llawn